Your browser doesn't support javascript.
loading
Pharmacological Targeting of IRE1 in Cancer.
Raymundo, Diana Pelizzari; Doultsinos, Dimitrios; Guillory, Xavier; Carlesso, Antonio; Eriksson, Leif A; Chevet, Eric.
Afiliação
  • Raymundo DP; Proteostasis and Cancer Team, INSERM U1242, COSS Laboratory, Université de Rennes, Rennes, France; Centre de Lutte contre le Cancer Eugène Marquis, Rennes, France.
  • Doultsinos D; Proteostasis and Cancer Team, INSERM U1242, COSS Laboratory, Université de Rennes, Rennes, France; Centre de Lutte contre le Cancer Eugène Marquis, Rennes, France.
  • Guillory X; Institut des Science Chimiques de Rennes, CNRS UMR6226, Université de Rennes, Rennes, France.
  • Carlesso A; Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
  • Eriksson LA; Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden. Electronic address: leif.eriksson@chem.gu.se.
  • Chevet E; Proteostasis and Cancer Team, INSERM U1242, COSS Laboratory, Université de Rennes, Rennes, France; Centre de Lutte contre le Cancer Eugène Marquis, Rennes, France. Electronic address: eric.chevet@inserm.fr.
Trends Cancer ; 6(12): 1018-1030, 2020 12.
Article em En | MEDLINE | ID: mdl-32861679

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Serina-Treonina Quinases / Inibidores de Proteínas Quinases / Endorribonucleases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Serina-Treonina Quinases / Inibidores de Proteínas Quinases / Endorribonucleases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article